Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), Calle Ramiro de Maeztu 9, E-28040 Madrid, Spain.
Trends Immunol. 2019 Mar;40(3):228-242. doi: 10.1016/j.it.2019.01.006. Epub 2019 Feb 15.
Neutrophils are the first responders to inflammation and infection. Recently, an elevated neutrophil-to-lymphocyte ratio has generally become a prognostic indicator of poor overall survival in cancer. Accordingly, heterogeneous ill-defined neutrophil-like populations have been increasingly recognized as important players in cancer development. In addition, neutrophil granule proteins released upon cell activation have been associated with tumor progression; this differential granule mobilization may allow neutrophils - and possibly associated cancer cells - to leave the bloodstream and enter inflamed/infected tissues. This review discusses and proposes how granule mobilization may facilitate neutrophil-mediated transport of cancer cells into different tissues as well as leading to different cellular phenotypes that underlie remarkable neutrophil plasticity. This concept might inform novel neutrophil-centered approaches to putative cancer therapies.
中性粒细胞是炎症和感染的第一反应者。最近,升高的中性粒细胞与淋巴细胞比值通常成为癌症总生存不良的预后指标。因此,异质的、定义不明确的中性粒细胞样群体越来越被认为是癌症发展的重要参与者。此外,细胞激活时释放的中性粒细胞颗粒蛋白与肿瘤进展有关;这种差异颗粒动员可能允许中性粒细胞 - 可能还有相关的癌细胞 - 离开血液进入炎症/感染组织。本综述讨论并提出了颗粒动员如何促进中性粒细胞介导的癌细胞向不同组织的运输,并导致不同的细胞表型,从而产生显著的中性粒细胞可塑性。这一概念可能为以中性粒细胞为中心的潜在癌症治疗方法提供信息。